Myxedema Coma: a Review

Abderrahim Talha, Bkiyar Houssam and Housni Brahim
Additional contact information
Abderrahim Talha: CHU Mohammed-VI Oujda, Morocco
Bkiyar Houssam: CHU Mohammed-VI Oujda, Morocco
Housni Brahim: CHU Mohammed-VI Oujda, Morocco

European Journal of Medical and Health Sciences, 2020, vol. 2, issue 3

Abstract: Myxedema coma, represents the extreme degree of severity of hypothyroidism, whose mortality can reach very high percentages, therefore, it is a true medical emergency. In general, its development is associated with the presence of a triggering factor in a controlled hypothyroid patient and manifests with multisystem alteration. Currently, tools have been developed for clinical diagnosis that use the profile and clinical models, and have good sensitivity-specificity. They allow an early diagnosis which favored the early start of treatment and therefore improves the prognosis. The patient with myxedema coma needs an integral approach, with intensive treatment and close monitoring of hemodynamic parameters. However, the basis of treatment remains hormone replacement, which should be initiated with a combination of levothyroxine and triiodothyronine.

Keywords: Myxedema Coma; Hypothyroidism; Intensive care (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://eu-opensci.org/index.php/ejmed/article/view/40349 Abstract page (text/html)
https://eu-opensci.org/index.php/ejmed/article/download/40349/8892 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:epw:ejmed0:v:2:y:2020:i:3:id:40349

DOI: 10.24018/ejmed.2020.2.3.349

Access Statistics for this article

More articles in European Journal of Medical and Health Sciences from European Open Science
Bibliographic data for series maintained by Support ().